United Kingdom Pharmaceuticals & Healthcare Report Q2 2018

United Kingdom Pharmaceuticals & Healthcare Report Q2 2018

BMI View:

Although still remote, the risk of a cliff edge Brexit has risen materially, raising concerns for pharmaceuticalcompanies and healthcare providers. The UK leaving the EU without a deal in place has the potential to have a wide-rangingnegative impact on the pharmaceuticals and healthcare sector - hurting research and development, the pace of local innovativedrug launches, medicine exports to the EU and the availability of skilled labour for the NHS.

BMI Industry View
Industry Forecast
Pharmaceutical Market Forecast
Healthcare Market Forecast
Prescription Drug Market Forecast
Patented Drug Market Forecast
Generic Drug Market Forecast
OTC Medicine Market Forecast
Pharmaceutical Trade Forecast
Industry Risk/Reward Index
Western Europe Pharmaceuticals: Large Market Sizes Boost Attractiveness
High Pharmaceutical Spending Boosts Innovative Pharmaceuticals Risk/Reward Index Score
Regulatory Development
Regulatory Review
Market Overview
Competitive Landscape
Company Profile
Demographic Forecast
Demographic Outlook
Pharmaceuticals & Healthcare Glossary

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook